2010
DOI: 10.1016/j.acuro.2010.05.013
|View full text |Cite
|
Sign up to set email alerts
|

¿Se ha de asumir el efecto de clase farmacológica entre los diferentes análogos de la hormona liberadora de la hormona luteinizante usados en el tratamiento del carcinoma de próstata?

Abstract: The current available evidence is not enough to support a presumed «drug class effect» among the various analogues in the treatment of prostate carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2012
2012
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 57 publications
0
0
0
Order By: Relevance